Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03676192 |
|---|---|
| Brief Title: | To Compare Efficacy and Safety of CT-P16 and EU-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer |
| First Submitted : | September 6, 2018 |
| First Submitted that Met QC Criteria : | September 16, 2018 |
| First Posted : | September 18, 2018 |
| Last Update Submitted that Met QC Criteria : | August 24, 2022 |
| Last Update Posted : | August 26, 2022 |